Valuation (16%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 0.00 | N/A |
| PEG Ratio (TTM) | N/A | N/A |
| P/S Ratio (TTM) | 324.77 | N/A |
| P/B Ratio (TTM) | 0.70 | N/A |
| P/FCF Ratio (TTM) | 0.00 | N/A |
| Price to 5YR AVG Earnings Ratio | -0.13 | N/A |
| Price to 5YR AVG FCF Ratio | -0.39 | N/A |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -23,587.96% | N/A |
| ROE (TTM) | -26,438.24% | N/A |
| Net Profit Margin (TTM) | -12,414,736.82% | N/A |
| ROIC 5YR AVG | -90.91% | N/A |
Growth (8%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -18,757.97% | -438.10% | -247.77% |
| Revenue | -68.39% | -27.44% | 60.80% |
| Net Income | -19,491.27% | -48.24% | -17.18% |
| Cash Flow | -74,728.33% | -45.38% | -18.78% |
Health (18%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 3.88 | N/A |
| Quick Ratio (TTM) | 0.20 | N/A |
| D/E Ratio (TTM) | 169.23 | N/A |
| Interest Coverage (TTM) | -259.53 | N/A |
| Piotroski F-Score | 3 | N/A |
| Altman Z-Score | N/A | N/A |
| LTL to 5YR AVG FCF | -0.07 | N/A |
| Shares Outstanding Growth 5YR AVG | 5.29% | N/A |